[Meloxicam (Mobic): a review of its pharmacological and clinical profile].
作者： Keiko OGINO , Kazushige SAITO , Takeshi OSUGI , Hisashi SATOH
DOI: 10.1254/FPJ.120.391
关键词:
摘要: … of meloxicam in the rat, with regard to inhibition of adjuvant arthritis, was several times greater than that of other NSAIDs. Meloxicam in … In clinical studies, meloxicam has shown reliable …
sci-hub.se 参考文章(13)
D.A. Kujubu, B.S. Fletcher, B.C. Varnum, R.W. Lim, H.R. Herschman, TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue Journal of Biological Chemistry. ,vol. 266, pp. 12866- 12872 ,(1991) , 10.1016/S0021-9258(18)98774-0
G. Engelhardt, R. Bögel, Chr. Schnitzler, R. Utzmann, Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings. Biochemical Pharmacology. ,vol. 51, pp. 29- 38 ,(1996) , 10.1016/0006-2952(95)02110-8
S. Kawai, Cyclooxygenase selectivity and the risk of gastro-intestinal complications of various non-steroidal anti-inflammatory drugs: A clinical consideration Inflammation Research. ,vol. 47, pp. 102- 106 ,(1998) , 10.1007/S000110050291
G. Engelhardt, D. Homma, K. Schlegel, R. Utzmann, C. Schnitzler, Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance Inflammation Research. ,vol. 44, pp. 423- 433 ,(1995) , 10.1007/BF01757699
T. D. Warner, F. Giuliano, I. Vojnovic, A. Bukasa, J. A. Mitchell, J. R. Vane, Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 7563- 7568 ,(1999) , 10.1073/PNAS.96.13.7563
G. Engelhardt, D. Homma, C. Schnitzler, Meloxicam: a potent inhibitor of adjuvant arthritis in the Lewis rat. Inflammation Research. ,vol. 44, pp. 548- 555 ,(1995) , 10.1007/BF01757360
Harvey R. Herschman, Prostaglandin synthase 2. Biochimica et Biophysica Acta. ,vol. 1299, pp. 125- 140 ,(1996) , 10.1016/0005-2760(95)00194-8
Keiko Ogino, Ko Hatanaka, Michiko Kawamura, Makoto Katori, Yoshiteru Harada, Evaluation of Pharmacological Profile of Meloxicam as an Anti-Inflammatory Agent, with Particular Reference to Its Relative Selectivity for Cyclooxygenase-2 Over Cyclooxygenase-1 Pharmacology. ,vol. 55, pp. 44- 53 ,(1997) , 10.1159/000139511
M. Pairet, J. van Ryn, H. Schierok, A. Mauz, G. Trummlitz, G. Engelhardt, Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4′-isomer Inflammation Research. ,vol. 47, pp. 270- 276 ,(1998) , 10.1007/S000110050329
W. L. Xie, J. G. Chipman, D. L. Robertson, R. L. Erikson, D. L. Simmons, EXPRESSION OF A MITOGEN-RESPONSIVE GENE ENCODING PROSTAGLANDIN SYNTHASE IS REGULATED BY MRNA SPLICING Proceedings of the National Academy of Sciences of the United States of America. ,vol. 88, pp. 2692- 2696 ,(1991) , 10.1073/PNAS.88.7.2692